Combination of compounds for treating or preventing skin diseases
    3.
    发明授权
    Combination of compounds for treating or preventing skin diseases 有权
    用于治疗或预防皮肤疾病的化合物的组合

    公开(公告)号:US08669233B2

    公开(公告)日:2014-03-11

    申请号:US13201762

    申请日:2010-02-16

    IPC分类号: A61K31/70

    摘要: A combination of compounds for treating skin diseases and particularly rosacea and ocular rosacea is described. The combination of a compound of the avermectin family or of the mylbemycin family with a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists is also described. In addition, a product in the form of a kit including: (a) a first composition containing a compound of the avermectin family or of the mylbemycin family, and (b) a second composition different from the first one and containing a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists, as a combination product to be used as a drug for treating and/or preventing skin diseases and particularly rosacea and ocular rosacea, wherein said first and second compositions can be applied simultaneously, separately or with a time delay is described.

    摘要翻译: 描述了用于治疗皮肤疾病,特别是红斑痤疮和眼酒渣酒的化合物的组合。 还描述了除虫菌素家族的化合物或米比霉素家族与α-1或α-2肾上腺素能受体激动剂家族的化合物的组合。 此外,试剂盒形式的产品包括:(a)含有阿维菌素家族或米尔霉素家族的化合物的第一种组合物,和(b)不同于第一种组合物的第二种组合物, 作为用作治疗和/或预防皮肤疾病,特别是红斑痤疮和酒渣酒的药物的组合产品,其中所述第一和第二组合物可以同时施用, 分别描述或延迟时间。

    COMBINATION OF COMPOUNDS FOR TREATING OR PREVENTING SKIN DISEASES
    7.
    发明申请
    COMBINATION OF COMPOUNDS FOR TREATING OR PREVENTING SKIN DISEASES 有权
    用于治疗或预防皮肤疾病的化合物的组合

    公开(公告)号:US20120035123A1

    公开(公告)日:2012-02-09

    申请号:US13201762

    申请日:2010-02-16

    摘要: A combination of compounds for treating skin diseases and particularly rosacea and ocular rosacea is described. The combination of a compound of the avermectin family or of the mylbemycin family with a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists is also described. In addition, a product in the form of a kit including: (a) a first composition containing a compound of the avermectin family or of the mylbemycin family, and (b) a second composition different from the first one and containing a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists, as a combination product to be used as a drug for treating and/or preventing skin diseases and particularly rosacea and ocular rosacea, wherein said first and second compositions can be applied simultaneously, separately or with a time delay is described.

    摘要翻译: 描述了用于治疗皮肤疾病,特别是红斑痤疮和眼酒渣酒的化合物的组合。 还描述了除虫菌素家族的化合物或米比霉素家族与α-1或α-2肾上腺素能受体激动剂家族的化合物的组合。 此外,试剂盒形式的产品包括:(a)含有阿维菌素家族或米尔霉素家族的化合物的第一种组合物,和(b)不同于第一种组合物的第二种组合物, 作为用作治疗和/或预防皮肤疾病,特别是红斑痤疮和酒渣酒的药物的组合产品,其中所述第一和第二组合物可以同时施用, 分别描述或延迟时间。

    Pharmaceutical compositions comprising calcitriol and a clobetasol propionate
    9.
    发明申请
    Pharmaceutical compositions comprising calcitriol and a clobetasol propionate 审中-公开
    包含骨化三醇和丙酸氯倍他索的药物组合物

    公开(公告)号:US20060009426A1

    公开(公告)日:2006-01-12

    申请号:US11154706

    申请日:2005-06-17

    IPC分类号: A61K31/59 A61K31/573

    摘要: Topically applicable pharmaceutical gel, cream, lotion, solution or ointment compositions contain synergistically effective amounts of a) calcitriol and b) clobetasol propionate, formulated into a topically applicable, pharmaceutically acceptable medium therefor, and are useful for the treatment of such dermatological afflictions or conditions as psoriasis, atopic dermatitis, contact dermatitis and seborrhoeic dermatitis.

    摘要翻译: 局部适用的药物凝胶,霜剂,洗剂,溶液或软膏组合物含有协同有效量的a)骨化三醇和b)配制成局部适用的药学上可接受的介质的丙酸氯倍他索,并且可用于治疗这种皮肤病的病症或病症 如牛皮癣,特应性皮炎,接触性皮炎和脂溢性皮炎。